This information is then used for the logical design of transition-state inhibitors which have the potential to be new biologically active agents. Some of these are in development to be drugs. Schramm's work has translated basic chemical understanding at the quantum mechanical level to a new approach to drug development.[5]
Schramm secured a postdoctoral position at the NASAAmes Research Center after graduation. Later he joined the Temple University School of Medicine as a faculty member. In 1987 he joined the faculty at Albert Einstein College of Medicine as professor and chair of the biochemistry department.[4]